Sector: Consumer Cyclicals | Industry: Miscellaneous Specialty Retailers |
Company Contact | |
Address: | 8740 S. SEPULVEDA BOULEVARD, SUITE 105 LOS ANGELES CA 90045 |
Tel: | N/A |
Website: | https://medmen.com |
IR: | See website |
Key People | ||
Amit Pandey Chief Financial Officer | Melony Valleau Chief Accounting Officer | Richard P. Ormond Chief Restructuring Officer |
Business Overview |
MedMen Enterprises Inc. is a retail cannabis company with an operational footprint in California, Nevada, Illinois, Massachusetts, and New York. The Company offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red, Moss and LuxLyte, through its premium retail stores, proprietary delivery service, as well as curbside and instore pickup. MedMen Buds, a loyalty program, provides access to promotions, product drops and content. It produces and curates the consumer product assortment for retail operations in its local communities with services and engaging in-store experience, combined with reward, delivery, and e-commerce programs. It also offers buds rewards, where buds members earn points with every purchase, plus exclusive access to drops and deals. The Company also provides gift cards. |
Financial Overview |
For the 39 weeks ended 25 March 2023, Medmen Enterprises Inc revenues decreased 22% to $86.8M. Net loss applicable to common stockholders excluding extraordinary items decreased 11% to $65.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects General and Administrative - Balancing v decrease of 68% to $12.2M (expense). |
Employees: | 702 as of Jun 25, 2022 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $466.95M as of Mar 25, 2023 |
Annual revenue (TTM): | $166.11M as of Mar 25, 2023 |
EBITDA (TTM): | -$20.94M as of Mar 25, 2023 |
Net annual income (TTM): | -$198.17M as of Mar 25, 2023 |
Free cash flow (TTM): | -$43.03M as of Mar 25, 2023 |
Net Debt Last Fiscal Year: | $440.42M as of Mar 25, 2023 |
Shares outstanding: | 1,441,683,450 as of Mar 25, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |